Affiliation: Tulane University
- Robust pro-inflammatory and lesser anti-inflammatory immune responses during primary simian varicella virus infection and reactivation in rhesus macaquesVicki Traina-Dorge
Division of Microbiology, Tulane National Primate Research Center, Tulane University, 18703 Three Rivers Road, Covington, LA, 70433, USA
J Neurovirol 20:526-30. 2014..Characterization of cytokine, chemokine and growth factor responses during different stages of varicella virus infection will facilitate immunotherapeutic and vaccine strategies. ..
- Increased cellular immune responses and CD4+ T-cell proliferation correlate with reduced plasma viral load in SIV challenged recombinant simian varicella virus - simian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaquesBapi Pahar
Division of Microbiology, Tulane National Primate Research Center, Tulane University School of Medicine, Covington, LA 70433, USA
Virol J 9:160. 2012....
- Molecular epidemiology of simian T-cell lymphotropic virus type 1 in wild and captive sooty mangabeysVicki L Traina-Dorge
Division of Microbiology and Immunology, Tulane National Primate Research Center, 18703 Three Rivers Rd, Covington, LA 70433, USA
J Virol 79:2541-8. 2005....
- Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primateVicki L Traina-Dorge
Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA
J Infect Dis 195:562-71. 2007..We conclude that SIV may have the potential to up-regulate HTLV-1 and disease expression...
- Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaquesV Traina-Dorge
Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, United States
Vaccine 28:6483-90. 2010....
- Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfectionMark A Beilke
Tulane University Health Sciences Center School of Medicine, New Orleans, Louisiana, USA
Clin Infect Dis 44:1229-34. 2007..The long-term effects of coinfection are unknown, and little information exists regarding how levels of HTLV-1/2 viral burden are affected by antiretroviral medications...